Mead Johnson Increases as Baby Illnesses Not Linked to Formula
This article is for subscribers only.
Mead Johnson Nutrition Co., maker of the world’s best-selling baby formulas, gained in early trading after U.S. regulators said they hadn’t found a connection between infant illnesses and the company’s products.
Mead Johnson rose 4.6 percent to $71.90 at 8:30 a.m. New York time. The Glenview, Illinois-based company’s shares increased 10 percent in 2011.